ASHLEY COURCHESNE: Open Payments
NPI 1922528645 · SAN MARCOS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$478 in 13 payments from 4 companies in 2025. Trend: 2023 $902 · 2024 $643 · 2025 $478
Food & beverage: $478
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 8 | $286 |
| MERZ NORTH AMERICA, INC. | 1 | $125 |
| Galderma Laboratories, L.P. | 2 | $36 |
| ABBVIE INC. | 2 | $31 |
Products named: DAXXIFY, DAXI, Xeomin, UBRELVY.
Industry payments across TX — which companies pay providers there.
